本季度信息
国药控股（股票代码：01099）公布2025年度财报。财报显示，公司在报告期内实现营收52,468,280,576.72元，同比增长3.70%。同期，公司扣除非经常性损益后的净利润为1,970,533,716.86元，同比下降1.28%。财报同时显示，经营活动产生的现金流量净额达到2,005,517,512.06元，同比上升20.88%。整体来看，公司业务规模稳步提升，盈利能力保持相对稳定。
业务分项
高管解读
本季度信息
国药控股（股票代码：01099）公布2025年度财报。财报显示，公司在报告期内实现营收52,468,280,576.72元，同比增长3.70%。同期，公司扣除非经常性损益后的净利润为1,970,533,716.86元，同比下降1.28%。财报同时显示，经营活动产生的现金流量净额达到2,005,517,512.06元，同比上升20.88%。整体来看，公司业务规模稳步提升，盈利能力保持相对稳定。
业务分项
高管解读
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.